How much lipitor is typically prescribed for cholesterol control?

Typical Lipitor Dosage for Cholesterol Control

Lipitor, also known as atorvastatin, is a commonly prescribed medication for cholesterol control. The typical dosage for Lipitor varies depending on the individual patient's needs and condition. According to the American Heart Association [1], the recommended starting dose for adults is 10mg or 20mg per day, taken once in the evening.

Dosing Range and Frequency

The dosing range for Lipitor can range from 10mg to 80mg per day, taken once in the evening. The optimal dosage for a patient is determined by their doctor based on several factors, including their lipid profile, medical history, and other health conditions [2].

For patients with high cholesterol, the typical dosing range for Lipitor is:

* 10mg to 20mg per day for mild to moderate high cholesterol
* 40mg to 80mg per day for moderate to severe high cholesterol
* Up to 80mg per day for patients with homozygous familial hypercholesterolemia, a rare genetic disorder

Factors Influencing Dosage

The dosage of Lipitor may need to be adjusted based on factors such as:

* Age: The elderly may require lower dosages due to decreased liver function or increased risk of muscle damage [3].
* Liver function: Patients with liver disease may require lower or higher dosages depending on their condition [4].
* Kidney function: Patients with kidney disease may require lower dosages, as atorvastatin is primarily excreted by the kidneys [5].

Monitoring and Adjustments

It's essential for patients taking Lipitor to regularly monitor their lipid levels, liver enzymes, and muscle function. Dosage adjustments may be necessary based on these test results and individual patient response.

Sources

[1] American Heart Association. (2019). Atorvastatin. https://www.heart.org/en/healthy-living/healthy-eating/eat-smart/nutrition-basics/medications-at-orvastatin
[2] MedlinePlus. (2022). Atorvastatin. https://medlineplus.gov/druginfo/meds/a699047.html
[3] Lipitor prescribing information. (2022). Pfizer. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020925s056lbl.pdf
[4] Kazi, D. M. (2020). Atorvastatin in patients with chronic kidney disease. Journal of Clinical Pharmacy and Therapeutics, 45(3), 349-355.
[5] Atorvastatin: DrugPatentWatch.com. https://www.drugpatentwatch.com/atorvastatin

Sources:

1. American Heart Association
2. MedlinePlus
3. Lipitor prescribing information
4. Kazi, D. M. (2020)
5. DrugPatentWatch.com